Skip to main content

Search form

  • Contact us
  • Home
  • About us
    • Aims and Overview
    • Oversight
    • Partners
    • Staff
    • Contact us
  • Research
    • Overcoming obstacles to implementation
    • Refining Endgame Strategies
    • Sustaining program achievements
    • Funding Opportunities
  • Projects
  • Publications
  • Tools and Resources
  • News
  • COR-NTD
    • NTD ConnectOR
    • Blog
    • NLCB
 
Home / COR-NTD / NTD ConnectOR / Fiji MOH

Fiji MOH

IDA Acceptability Study (Fiji)

26 June 2017
Fiji MOH, Bruyere Research Institute, Murdoch Children's Research Institute, Bruyere Research Institute, DOLF, Bruyere Research Institute, NTD-SC, Bruyere Research Institute

Assess the overall acceptability of the 3-drug treatment in the community as compared to the 2-drug treatment

Countries: Fiji
Diseases: Lymphatic filariasis

IDA-Triple Drug Therapy Clinical Trial in Fiji

26 June 2017
Fiji MOH, Murdoch Children's Research Institute, DOLF, Murdoch Children's Research Institute, NTD-SC, Murdoch Children's Research Institute

Clinical Trial Triple Drug Study for LF

Countries: Fiji
Diseases: Lymphatic filariasis | Scabies

Subscribe

Contact us

Find us on Google maps

Neglected Tropical Diseases Support Center
The Task Force for Global Health
330 West Ponce de Leon Avenue
Decatur, Georgia 30030 USA


  • Privacy & disclaimer
  • Sitemap
  • © 2021 Neglected Tropical Diseases Support Center
Website by Manta Ray Media